Sitemap | Careers | Contact Us     Other Country Sites  Search English | Français  Select a Country Ranbaxy Corporate Ranbaxy USA

PRODUCTS  New Products             All Products RANTM-AMLODIPINE RANTM-ATENOLOL RANTM-CARVEDILOL RAN™-CEFPROZIL RAN™-CIPROFLOX RANTM-CIPROFLOXACIN RANTM-CITALO RANTM-CITALOPRAM RANTM-DOMPERIDONE NRANTM-FENTANYL MATRIX PATCH NRANTM-FENTANYL TRANSDERMAL SYSTEM RANTM-LISINOPRIL RANTM-LOVASTATIN RANTM-METFORMIN RANTM-ONDANSETRON RANTM-PANTOPRAZOLE RANTM-PRAVASTATIN RANTM-RABEPRAZOLE RANTM-RAMIPRIL RANTM-RISPERIDONE RANTM-ROPINIROLE RANTM-SIMVASTATIN   RANTM-TAMSULOSIN   RANTM-ZOPICLONE   Other Ranbaxy Sites --SELECT-- Aid on Aids Ohm Labs Ranbaxy Science Foundation Jul 29, 2009 RANBAXY GAINS APPROVAL TO MARKET RANTM-ROPINIROLE TABLETS IN CANADA Jul 21, 2009 RANBAXY RECEIVES FINAL APPROVAL TO MANUFACTURE AND MARKET RANTM-SIMVASTATIN TABLETS IN CANADA Jul 20, 2009 RANBAXY RECEIVES FINAL APPROVAL TO MANUFACTURE AND MARKET RANTM-AMLODIPINE TABLETS IN CANADA Read more news from Ranbaxy >> Business Opportunities API Development and Production Dosage Form Development and Manufacturing Contract Manufacturing Sales and Marketing Marketing Strategies Licensing          Terms of Use | Privacy Policy | Compliance Policy          The information on this website is solely for Canadian Residents.© Ranbaxy Laboratories Limited          All rights reserved.